Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition

Journal of Immunology

Volumn 193, Issue 9, 2014, Pages 4322-4334

  Dinter, Jens ^a   Gourdain, Pauline ^a   Lai, Nicole Y ^a   Duong, Ellen ^a   Bracho Sanchez, Edith ^a   Rucevic, Marijana ^a   Liebesny, Paul H ^a   Xu, Yang ^a   Shimada, Mariko ^a   Ghebremichael, Musie ^a   Kavanagh, Daniel G ^a   Le Gall, Sylvie ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEINASE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; MEMBRANE ANTIGEN; PEPTIDE; PEPTIDE HYDROLASE; PROTEASOME; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; MASS SPECTROMETRY; MONOCYTE; NONHUMAN; PROTEIN DEGRADATION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MONONUCLEAR CELL; PROTEIN STABILITY; TRANSFORMED CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, SURFACE; CELL LINE, TRANSFORMED; CYTOSOL; DENDRITIC CELLS; EPITOPES; HIV; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MONOCYTES; PEPTIDE HYDROLASES; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; PROTEOLYSIS; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTORS;

EID: 84908122993     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400491     Document Type: Article

References (81)

1. Stebbing, J., B. Gazzard, and D. C. Douek. 2004. Where does HIV live? N. Engl. J. Med. 350: 1872-1880.
2. Eisele, E., and R. F. Siliciano. 2012. Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity 37: 377-388.
3. Fujiwara, M., and M. Takiguchi. 2007. HIV-1-specific CTLs effectively suppress replication of HIV-1 in HIV-1-infected macrophages. Blood 109: 4832-4838.
4. Buseyne, F., S. Le Gall, C. Boccaccio, J. P. Abastado, J. D. Lifson, L. O. Arthur, Y. Rivière, J. M. Heard, and O. Schwartz. 2001. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat. Med. 7: 344-349.
5. Lubong Sabado, R., D. G. Kavanagh, D. E. Kaufmann, K. Fru, E. Babcock, E. Rosenberg, B. Walker, J. Lifson, N. Bhardwaj, and M. Larsson. 2009. In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection. PLoS One 4: e4256.
6. Larsson, M., J. F. Fonteneau, M. Lirvall, P. Haslett, J. D. Lifson, and N. Bhardwaj. 2002. Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus. AIDS 16: 1319-1329.
7. Severino, M. E., N. V. Sipsas, P. T. Nguyen, S. A. Kalams, B. D. Walker, R. P. Johnson, and O. O. Yang. 2000. Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes. J. Virol. 74: 6695-6699.
8. Neefjes, J., M. L. Jongsma, P. Paul, and O. Bakke. 2011. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11: 823-836.
9. Grant, E. P., M. T. Michalek, A. L. Goldberg, and K. L. Rock. 1995. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J. Immunol. 155: 3750-3758.
10. Georgiadou, D., A. Hearn, I. Evnouchidou, A. Chroni, L. Leondiadis, I. A. York, K. L. Rock, and E. Stratikos. 2010. Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1. J. Immunol. 185: 1584-1592.
11. Towne, C. F., I. A. York, J. Neijssen, M. L. Karow, A. J. Murphy, D. M. Valenzuela, G. D. Yancopoulos, J. J. Neefjes, and K. L. Rock. 2005. Leucine aminopeptidase is not essential for trimming peptides in the cytosol or generating epitopes for MHC class I antigen presentation. J. Immunol. 175: 6605-6614.
12. Kessler, J. H., S. Khan, U. Seifert, S. Le Gall, K. M. Chow, A. Paschen, S. A. Bres-Vloemans, A. de Ru, N. van Montfoort, K. L. Franken, et al. 2011. Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nat. Immunol. 12: 45-53.
13. York, I. A., A. X. Y. Mo, K. Lemerise, W. Zeng, Y. Shen, C. R. Abraham, T. Saric, A. L. Goldberg, and K. L. Rock. 2003. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity 18: 429-440.
14. Firat, E., J. Huai, L. Saveanu, S. Gaedicke, P. Aichele, K. Eichmann, P. van Endert, and G. Niedermann. 2007. Analysis of direct and cross-presentation of antigens in TPPII knockout mice. J. Immunol. 179: 8137-8145.
15. Reits, E., J. Neijssen, C. Herberts, W. Benckhuijsen, L. Janssen, J. W. Drijfhout, and J. Neefjes. 2004. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20: 495-506.
16. Serwold, T., S. Gaw, and N. Shastri. 2001. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat. Immunol. 2: 644-651.
17. York, I. A., S. C. Chang, T. Saric, J. A. Keys, J. M. Favreau, A. L. Goldberg, and K. L. Rock. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3: 1177-1184.
18. Hammer, G. E., F. Gonzalez, M. Champsaur, D. Cado, and N. Shastri. 2006. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat. Immunol. 7: 103-112.
19. Saveanu, L., O. Carroll, V. Lindo, M. Del Val, D. Lopez, Y. Lepelletier, F. Greer, L. Schomburg, D. Fruci, G. Niedermann, and P. M. van Endert. 2005. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6: 689-697.
20. Tanioka, T., A. Hattori, S. Masuda, Y. Nomura, H. Nakayama, S. Mizutani, and M. Tsujimoto. 2003. Human leukocyte-derived arginine aminopeptidase: the third member of the oxytocinase subfamily of aminopeptidases. J. Biol. Chem. 278: 32275-32283.
21. Lazaro, E., S. B. Godfrey, P. Stamegna, T. Ogbechie, C. Kerrigan, M. Zhang, B. D. Walker, and S. Le Gall. 2009. Differential HIV epitope processing in monocytes and CD4 T cells affects cytotoxic T lymphocyte recognition. J. Infect. Dis. 200: 236-243.
22. Butz, E. A., and M. J. Bevan. 1998. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells. J. Immunol. 160: 2139-2144.
23. Crowe, S. R., S. J. Turner, S. C. Miller, A. D. Roberts, R. A. Rappolo, P. C. Doherty, K. H. Ely, and D. L. Woodland. 2003. Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections. J. Exp. Med. 198: 399-410.
24. Delamarre, L., M. Pack, H. Chang, I. Mellman, and E. S. Trombetta. 2005. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307: 1630-1634.
25. Griffin, T. A., D. Nandi, M. Cruz, H. J. Fehling, L. V. Kaer, J. J. Monaco, and R. A. Colbert. 1998. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J. Exp. Med. 187: 97-104.
26. Beninga, J., K. L. Rock, and A. L. Goldberg. 1998. Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J. Biol. Chem. 273: 18734-18742.
27. Saric, T., S. C. Chang, A. Hattori, I. A. York, S. Markant, K. L. Rock, M. Tsujimoto, and A. L. Goldberg. 2002. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat. Immunol. 3: 1169-1176.
28. Morel, S., F. Lévy, O. Burlet-Schiltz, F. Brasseur, M. Probst-Kepper, A. L. Peitrequin, B. Monsarrat, R. Van Velthoven, J. C. Cerottini, T. Boon, et al. 2000. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12: 107-117.
29. Sijts, A. J., S. Standera, R. E. Toes, T. Ruppert, N. J. Beekman, P. A. van Veelen, F. A. Ossendorp, C. J. Melief, and P. M. Kloetzel. 2000. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immuno-proteasomes in infected cells. J. Immunol. 164: 4500-4506.
30. van Hall, T., A. Sijts, M. Camps, R. Offringa, C. Melief, P.-M. Kloetzel, and F. Ossendorp. 2000. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28. J. Exp. Med. 192: 483-494.
31. Li, J., B. Schuler-Thurner, G. Schuler, C. Huber, and B. Seliger. 2001. Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation. Int. Immunol. 13: 1515-1523.
32. Macagno, A., M. Gilliet, F. Sallusto, A. Lanzavecchia, F. O. Nestle, and M. Groettrup. 1999. Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur. J. Immunol. 29: 4037-4042.
33. Macagno, A., L. Kuehn, R. de Giuli, and M. Groettrup. 2001. Pronounced up-regulation of the PA28alpha/beta proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation. Eur. J. Immunol. 31: 3271-3280.
34. Ossendorp, F., N. Fu, M. Camps, F. Granucci, S. J. Gobin, P. J. van den Elsen, D. Schuurhuis, G. J. Adema, G. B. Lipford, T. Chiba, et al. 2005. Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells. J. Immunol. 174: 7815-7822.
35. Crespo, M. I., E. R. Zacca, N. G. Núñez, R. P. Ranocchia, M. Maccioni, B. A. Maletto, M. C. Pistoresi-Palencia, and G. Morón. 2013. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface. J. Immunol. 190: 948-960.
36. Wille-Reece, U., B. J. Flynn, K. Loré, R. A. Koup, R. M. Kedl, J. J. Mattapallil, W. R. Weiss, M. Roederer, and R. A. Seder. 2005. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc. Natl. Acad. Sci. USA 102: 15190-15194.
37. Wille-Reece, U., C. Y. Wu, B. J. Flynn, R. M. Kedl, and R. A. Seder. 2005. Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses. J. Immunol. 174: 7676-7683.
38. Loré, K., M. R. Betts, J. M. Brenchley, J. Kuruppu, S. Khojasteh, S. Perfetto, M. Roederer, R. A. Seder, and R. A. Koup. 2003. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J. Immunol. 171: 4320-4328.
39. Rodríguez-García, M., F. Porichis, O. G. de Jong, K. Levi, T. J. Diefenbach, J. D. Lifson, G. J. Freeman, B. D. Walker, D. E. Kaufmann, and D. G. Kavanagh. 2011. Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. J. Leukoc. Biol. 89: 507-515.
40. Pertel, T., C. Reinhard, and J. Luban. 2011. Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon. Retrovirology 8: 49.
41. Le Gall, S., P. Stamegna, and B. D. Walker. 2007. Portable flanking sequences modulate CTL epitope processing. J. Clin. Invest. 117: 3563-3575.
42. Zhang, S. C., E. Martin, M. Shimada, S. B. Godfrey, J. Fricke, S. Locastro, N. Y. Lai, P. Liebesny, J. M. Carlson, C. J. Brumme, et al. 2012. Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individuals. J. Immunol. 188: 5924-5934.
43. Lazaro, E., C. Kadie, P. Stamegna, S. C. Zhang, P. Gourdain, N. Y. Lai, M. Zhang, S. A. Martinez, D. Heckerman, and S. Le Gall. 2011. Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape. J. Clin. Invest. 121: 2480-2492.
44. Lattanzi, L., C. Rozera, D. Marescotti, G. D'Agostino, L. Santodonato, S. Cellini, F. Belardelli, R. Gavioli, and M. Ferrantini. 2011. IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity. Immunobiology 216: 537-547.
45. Mathews, S. T., E. P. Plaisance, and T. Kim. 2009. Imaging systems for westerns: chemiluminescence vs. infrared detection. Methods Mol. Biol. 536: 499-513.
46. Walker, B. D., C. Flexner, K. Birch-Limberger, L. Fisher, T. J. Paradis, A. Aldovini, R. Young, B. Moss, and R. T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86: 9514-9518.
47. Llano, A., A. Williams, A. Olvera, S. Silva-Arrieta, and C. Brander. 2013. Best-Characterized HIV-1 CTL Epitopes: The 2013 Update. In HIV Molecular Immunology 2013. K. Yusim, B. Korber, C. Brander, D. H. Barouch, R. de Boer, B. F. Haynes, R. A. Koup, J. P. Moore, B. D. Walker, and D. I. Watkins, eds. Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, NM. p. 3-25.
48. Yu, X. G., M. M. Addo, E. S. Rosenberg, W. R. Rodriguez, P. K. Lee, C. A. Fitzpatrick, M. N. Johnston, D. Strick, P. J. Goulder, B. D. Walker, and M. Altfeld. 2002. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J. Virol. 76: 8690-8701.
49. Brumme, Z. L., M. John, J. M. Carlson, C. J. Brumme, D. Chan, M. A. Brockman, L. C. Swenson, I. Tao, S. Szeto, P. Rosato, et al. 2009. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS One 4: e6687.
50. Château, M. T., V. Robert-Hebmann, C. Devaux, J. B. Lazaro, B. Canard, and O. Coux. 2001. Human monocytes possess a serine protease activity capable of degrading HIV-1 reverse transcriptase in vitro. Biochem. Biophys. Res. Commun. 285: 863-872.
51. López, D., B. C. Gil-Torregrosa, C. Bergmann, and M. Del Val. 2000. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation. J. Immunol. 164: 5070-5077.
52. Tenzer, S., E. Wee, A. Burgevin, G. Stewart-Jones, L. Friis, K. Lamberth, C. H. Chang, M. Harndahl, M. Weimershaus, J. Gerstoft, et al. 2009. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat. Immunol. 10: 636-646.
53. Almeida, J. R., D. A. Price, L. Papagno, Z. A. Arkoub, D. Sauce, E. Bornstein, T. E. Asher, A. Samri, A. Schnuriger, I. Theodorou, et al. 2007. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204: 2473-2485.
54. Almeida, J. R., D. Sauce, D. A. Price, L. Papagno, S. Y. Shin, A. Moris, M. Larsen, G. Pancino, D. C. Douek, B. Autran, et al. 2009. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 113: 6351-6360.
55. Dong, T., G. Stewart-Jones, N. Chen, P. Easterbrook, X. Xu, L. Papagno, V. Appay, M. Weekes, C. Conlon, C. Spina, et al. 2004. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J. Exp. Med. 200: 1547-1557.
56. Chen, H., Z. M. Ndhlovu, D. Liu, L. C. Porter, J. W. Fang, S. Darko, M. A. Brockman, T. Miura, Z. L. Brumme, A. Schneidewind, et al. 2012. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat. Immunol. 13: 691-700.
57. Betts, M. R., M. C. Nason, S. M. West, S. C. De Rosa, S. A. Migueles, J. Abraham, M. M. Lederman, J. M. Benito, P. A. Goepfert, M. Connors, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
58. Migueles, S. A., A. C. Laborico, W. L. Shupert, M. S. Sabbaghian, R. Rabin, C. W. Hallahan, D. Van Baarle, S. Kostense, F. Miedema, M. McLaughlin, et al. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3: 1061-1068.
59. Migueles, S. A., C. M. Osborne, C. Royce, A. A. Compton, R. P. Joshi, K. A. Weeks, J. E. Rood, A. M. Berkley, J. B. Sacha, N. A. Cogliano-Shutta, et al. 2008. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29: 1009-1021.
60. Altfeld, M., E. T. Kalife, Y. Qi, H. Streeck, M. Lichterfeld, M. N. Johnston, N. Burgett, M. E. Swart, A. Yang, G. Alter, et al. 2006. HLA class I alleles that contribute strongly to the initial CD8+ T cell responses against HIV-1 are associated with delayed progression to AIDS. PLoS Med. 3: 1851-1863.
61. Pereyra, F., X. Jia, P. J. McLaren, A. Telenti, P. I. de Bakker, B. D. Walker, S. Ripke, C. J. Brumme, S. L. Pulit, M. Carrington, et al; International HIV Controllers Study. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330: 1551-1557.
62. Trachtenberg, E., B. Korber, C. Sollars, T. B. Kepler, P. T. Hraber, E. Hayes, R. Funkhouser, M. Fugate, J. Theiler, Y. S. Hsu, et al. 2003. Advantage of rare HLA supertype in HIV disease progression. Nat. Med. 9: 928-935.
63. Kaslow, R. A., M. Carrington, R. Apple, L. Park, A. Muñoz, A. J. Saah, J. J. Goedert, C. Winkler, S. J. O'Brien, C. Rinaldo, et al. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2: 405-411.
64. Pereyra, F., D. Heckerman, J. M. Carlson, C. Kadie, D. Z. Soghoian, D. Karel, A. Goldenthal, O. B. Davis, C. E. DeZiel, T. Lin, et al. 2014. HIV control is mediated in part by CD8+ T-cell targeting of specific epitopes. J. Virol. doi: 10.1128/JVI.01004-14.
65. Sabado, R. L., E. Babcock, D. G. Kavanagh, V. Tjomsland, B. D. Walker, J. D. Lifson, N. Bhardwaj, and M. Larsson. 2007. Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1. Eur. J. Immunol. 37: 1752-1763.
66. Tjomsland, V., R. Ellegård, A. Burgener, K. Mogk, K. F. Che, G. Westmacott, J. Hinkula, J. D. Lifson, and M. Larsson. 2013. Complement opsonization of HIV-1 results in a different intracellular processing pattern and enhanced MHC class I presentation by dendritic cells. Eur. J. Immunol. 43: 1470-1483.
67. Beignon, A. S., K. McKenna, M. Skoberne, O. Manches, I. da Silva, D. G. Kavanagh, M. Larsson, R. J. Gorelick, J. D. Lifson, and N. Bhardwaj. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115: 3265-3275.
68. Jouve, M., N. Sol-Foulon, S. Watson, O. Schwartz, and P. Benaroch. 2007. HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages. Cell Host Microbe 2: 85-95.
69. Raposo, G., M. Moore, D. Innes, R. Leijendekker, A. Leigh-Brown, P. Benaroch, and H. Geuze. 2002. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3: 718-729.
70. Palucka, K., J. Banchereau, and I. Mellman. 2010. Designing vaccines based on biology of human dendritic cell subsets. Immunity 33: 464-478.
71. Bozzacco, L., C. Trumpfheller, F. P. Siegal, S. Mehandru, M. Markowitz, M. Carrington, M. C. Nussenzweig, A. G. Piperno, and R. M. Steinman. 2007. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc. Natl. Acad. Sci. USA 104: 1289-1294.
72. Chatterjee, B., A. Smed-Sörensen, L. Cohn, C. Chalouni, R. Vandlen, B. C. Lee, J. Widger, T. Keler, L. Delamarre, and I. Mellman. 2012. Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells. Blood 120: 2011-2020.
73. Quinn, K. M., A. Yamamoto, A. Costa, P. A. Darrah, R. W. Lindsay, S. T. Hegde, T. R. Johnson, B. J. Flynn, K. Loré, and R. A. Seder. 2013. Coadministration of polyinosinic: polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity. J. Immunol. 191: 5085-5096.
74. Wille-Reece, U., B. J. Flynn, K. Loré, R. A. Koup, A. P. Miles, A. Saul, R. M. Kedl, J. J. Mattapallil, W. R. Weiss, M. Roederer, and R. A. Seder. 2006. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J. Exp. Med. 203: 1249-1258.
75. McCurley, N., and I. Mellman. 2010. Monocyte-derived dendritic cells exhibit increased levels of lysosomal proteolysis as compared to other human dendritic cell populations. PLoS One 5: e11949.
76. Dudziak, D., A. O. Kamphorst, G. F. Heidkamp, V. R. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, K. Liu, H. W. Lee, C. G. Park, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315: 107-111.
77. Cohn, L., B. Chatterjee, F. Esselborn, A. Smed-Sorensen, N. Nakamura, C. Chalouni, B. C. Lee, R. Vandlen, T. Keler, P. Lauer, et al. 2013. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation. J. Exp. Med. 210: 1049-1063.
78. Idoyaga, J., A. Lubkin, C. Fiorese, M. H. Lahoud, I. Caminschi, Y. Huang, A. Rodriguez, B. E. Clausen, C. G. Park, C. Trumpfheller, and R. M. Steinman. 2011. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc. Natl. Acad. Sci. USA 108: 2384-2389.
79. Flamar, A. L., Y. Xue, S. M. Zurawski, M. Montes, B. King, L. Sloan, S. Oh, J. Banchereau, Y. Levy, and G. Zurawski. 2013. Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells. AIDS 27: 2041-2051.
80. Ferguson, A. L., J. K. Mann, S. Omarjee, T. Ndung'u, B. D. Walker, and A. K. Chakraborty. 2013. Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design. Immunity 38: 606-617.
81. Stephenson, K. E., and D. H. Barouch. 2013. A global approach to HIV-1 vaccine development. Immunol. Rev. 254: 295-304.